Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on March 25, 2025
Wireless Broadband Alliance Announces Wi-Fi 7 trials achieving 4.9 Gbps and improved stability over Wi-Fi 6 in multi-dwelling environments
EIN Presswire
·
March 25, 2025
LG U+ and Intel Conduct Successful Wi-Fi 7 Field Trial in Multi-dwelling Units to Address Performance and Interference Needs in the Residential Market LONDON, UNITED KINGDOM, March 25, 2025 /EINPresswire.com/ -- The Wireless Broadband Alliance (WBA), …
Synetica Unveils enLink Status-DP: Ultimate LoRaWAN Differential Pressure Sensor With Superior Sensor Technology HV210
EIN Presswire
·
March 25, 2025
LOS GATOS, CA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Synetica, a leading provider of wireless environmental sensing solutions, announces the launch of the enLink Status-DP. This next-generation LoRaWAN differential pressure sensor redefines …
Cinema8 shortlisted for tech award recognising cambridge-built ai video platform
EIN Presswire
·
March 25, 2025
Cinema8, an AI-powered video platform built in Cambridge, has been named a finalist in the 2025 Cambridge Independent Science and Technology Awards. CAMBRIDGE, CAMBRIDGESHIRE, UNITED KINGDOM, March 25, 2025 /EINPresswire.com/ -- The nomination …
Bombardier Defense Announces Order of Two Challenger 650 Aircraft Destined for Intelligence, Surveillance and Reconnaissance missions in Australia
GlobeNewswire
·
March 25, 2025
Principle Finance, a renowned provider of customised operating lease for aircraft in Australia, placed an order for 2 Challenger 650 aircraft. Purchase was confirmed during a signing ceremony at the opening of the Avalon Australian International Airshow in …
Bombardier Défense annonce une commande de deux avions Challenger 650 destinés aux missions de renseignement, surveillance et reconnaissance en Australie
GlobeNewswire
·
March 25, 2025
Principle Finance, fournisseur réputé d’avions en location-exploitation personnalisée en Australie, a commandé deux avions Challenger 650 L’achat a été confirmé lors d’une cérémonie de signature à l’ouverture du salon aéronautique international d’Avalon, …
CISO Global Announces Pay Off of Highest-Interest Debt, Extends $7M in Convertible Notes
GlobeNewswire
·
March 25, 2025
Scottsdale, Ariz., March 25, 2025 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ: CISO), an industry leader in AI-powered cybersecurity software, managed cybersecurity, and compliance, announced it has successfully paid off its highest-interest loans as …
ECFI Revolutionizes Financial Education Through AI-Driven Investment Strategies
EIN Presswire
·
March 25, 2025
DENVER, CO, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Ecole de Commerce Fusion Innovation (ECFI), also known as Fusion Innovation Business School, has established itself as a pioneering institution at the intersection of financial education, …
Bicara Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2025
GlobeNewswire
·
March 25, 2025
BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that three abstracts …
Blueberries Medical Announces C$1 Million Non-Brokered Private Placement
GlobeNewswire
·
March 25, 2025
TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce a non- …
Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
March 25, 2025
One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in patients with high-grade serous ovarian cancer (HGSOC) Three additional posters highlighting the potential for broad …
CariPower Becomes First Order Provider Chosen by Obyte’s Decentralized Governance
EIN Presswire
·
March 25, 2025
CariPower becomes the first Order Provider chosen by Obyte’s governance introduced in November 2024. Obyte is a fully decentralized DAG-based crypto network. VADUZ, LIECHTENSTEIN, March 25, 2025 /EINPresswire.com/ -- Obyte, a leading decentralized …
Foghorn Therapeutics Announces New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and EP300 Degrader Programs at 2025 AACR Meeting
GlobeNewswire
·
March 25, 2025
- FHD-909 (LY4050784) advancing in an ongoing Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population - Oral presentation on preclinical data for FHD-909 in combination with chemotherapy, …
iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025
GlobeNewswire
·
March 25, 2025
WATERTOWN, Mass. and GOSSELIES, Belgium, March 25, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for …
IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
March 25, 2025
• New non-clinical data strengthens evidence of contributions of IO102 and IO103 to tumor growth control through target specific T-cell activation, offering a distinct and complementary approach to checkpoint inhibitors • New preclinical data for IO170 add …
Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting
GlobeNewswire
·
March 25, 2025
Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Erasca will also present potential first-in-class examples of direct SMP complex inhibitors, representing a new approach to block the RAS/ …
Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting
GlobeNewswire
·
March 25, 2025
SAN FRANCISCO, March 25, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
March 25, 2025
WALTHAM, Mass. and BOULDER, Colo., March 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced four preclinical poster …
Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting
GlobeNewswire
·
March 25, 2025
New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the American Association for Cancer Research (AACR) Annual Meeting These data will further add to the already strong clinical data package for EVX-01 The trial …
Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting
GlobeNewswire
·
March 25, 2025
Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327, exhibits anti-tumor activity and a favorable …
NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market
GlobeNewswire
·
March 25, 2025
WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (“NeOnc” or the “Company,” to be listed on the NASDAQ Global Market under the symbol: NTHI), a clinical-stage medical biotechnology company, today announced that …